Medicine and Dentistry
Methylation
100%
Promoter Region
100%
Malignant Neoplasm
100%
Clinical Trial
100%
Histone Deacetylase Inhibitor
100%
Cancer Therapy
100%
DNA Methylation
100%
Histone Deacetylase
100%
Epigenomics
100%
Molecularly Targeted Therapy
100%
Retinoid
100%
Genetic Transcription
100%
DNA Methyltransferase Inhibitor
100%
DNA Methyltransferase
100%
Chromatin Remodeling
100%
Histone Code
100%
Cytotoxic Agent
100%
Steroid Hormone
100%
Keyphrases
Therapeutic Target
100%
In Cancer
100%
Cancer Therapy
100%
Translational Science
100%
Baltimore
100%
Re-expression
100%
Epigenetic Modification
50%
Promoter Methylation
50%
Clinical Trials
50%
DNA Methylation (DNAm)
50%
Histone Deacetylase Inhibitor (HDACi)
50%
Cytotoxic Drugs
50%
Epigenetics
50%
Clinical Investigation
50%
Histone Deacetylase 1 (HDAC1)
50%
Gene Transcription
50%
Steroid Hormones
50%
Preclinical Investigation
50%
Chromatin Remodeling
50%
Retinoids
50%
Drug Class
50%
Maryland
50%
DNA Methyltransferase 1 (DNMT1)
50%
Transcriptional Control
50%
DNA Methyltransferase Inhibitor
50%
Hormone Drugs
50%
Histone Code
50%
Feasible Application
50%
Biochemistry, Genetics and Molecular Biology
Histone Deacetylase
100%
DNA Methyltransferase
100%
Methylation
50%
Epigenetics
50%
Promoter Region
50%
Clinical Trial
50%
DNA Methylation
50%
Epigenomics
50%
Epigenetics
50%
Genetic Transcription
50%
Chromatin Remodeling
50%
Retinoid
50%
Histone Code
50%
Targeted Therapy
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Clinical Trial
33%
Histone Deacetylase Inhibitor
33%
Histone
33%
Retinoid
33%
Histone Deacetylase
33%
DNA Methyltransferase
33%
DNA Methyltransferase Inhibitor
33%
Cytotoxic Agent
33%
Steroid Hormone
33%